From the TATA box to alternative splicing and noncoding RNAs, scientists are uncovering the intricate choreography that controls gene expression. These molecular mechanisms determine when, where, and ...

Patient was dosed at NYU Langone Health under the supervision of Dr. Alexandra Miller, Chief of Neuro-Oncology & Co-Director of Brain and Spine Tumor Center, Perlmutter Cancer CenterData ...

Khondrion announced that the first patient has been dosed in the Phase 3 study evaluating sonlicromanol in m.3243A>G Primary ...

Led by researchers from Heidelberg Faculty of Medicine at Heidelberg University and the University of California, San ...

The shape is, in the language of scholars, the monomyth or aptly called, the Hero's Journey. Gilgamesh can be counted as the earliest example of fantasy literature. A ruler seeking the elixir of life, ...

Enrollment continues to progress in Phase 3 AURORA trial of Descartes-08 in myasthenia gravis Phase 2 TRITON trial of Descartes-08 in ...

Primer design, a vital step in PCR and DNA sequencing, is being reshaped by automation and AI-powered tools. Moving beyond traditional manual workflows, advanced computational platforms and ...

Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that an abstract highlighting preclinical data from SG293, ...

Chemokines, acting as "traffic controllers" in the tumor microenvironment, regulate immune cell infiltration and local ...

PBGENE-HBV is Precision's wholly owned in vivo gene editing program under investigation in a global first-in-human clinical trial, which is designed to be a potentially curative treatment for chronic ...